SEC Filings | Madrigal Pharmaceuticals.

Filing date	Form	Description	View
January 18, 2024	4	Statement of changes in beneficial ownership of securities	0000950170-24-005297.pdf 0000950170-24-005297.rtf 0000950170-24-005297.xls
January 18, 2024	4	Statement of changes in beneficial ownership of securities	0000950170-24-005304.pdf 0000950170-24-005304.rtf 0000950170-24-005304.xls
January 17, 2024	CORRESP	CORRESP	0001193125-24-009389.pdf 0001193125-24-009389.rtf
January 08, 2024	8-K	Report of unscheduled material events or corporate event	0001193125-24-004269.pdf 0001193125-24-004269.rtf 0001193125-24-004269.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
January 03, 2024	UPLOAD	UPLOAD	0000000000-24-000087.pdf 0000000000-24-000087.rtf
December 18, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-071116.pdf 0000950170-23-071116.rtf 0000950170-23-071116.xls
December 14, 2023	4	Statement of changes in beneficial ownership of securities	0000950170-23-070416.pdf 0000950170-23-070416.rtf 0000950170-23-070416.xls
December 14, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-058691.pdf 0001209191-23-058691.rtf 0001209191-23-058691.xls
December 14, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-058693.pdf 0001209191-23-058693.rtf 0001209191-23-058693.xls
December 14, 2023	CORRESP	CORRESP	0001193125-23-295310.pdf 0001193125-23-295310.rtf 0001193125-23-295310.xls

Data provided by Kaleidoscope.